期刊文献+

不同血液肿瘤细胞株survivin基因和蛋白表达及意义的研究 被引量:2

Expression of survivin gene and protein in hematological tumor cell lines
下载PDF
导出
摘要 目的:研究survivin在不同血液肿瘤细胞株(Jurkat,Raji,EL-4,K562,K562/AO2)的表达,并探讨其与相关因素的关系。方法:应用RT-PCR技术检测survivin mRNA在各细胞株的表达,用免疫组化法检测survivin蛋白的表达,流式细胞仪检测细胞周期。结果:survivin mRNA在4种人源性细胞株(Jurkat,Raji,K562,K562/AO2)中均有表达,耐药株K562/AO2高于其他细胞株;免疫组化结果显示survivin蛋白在胞核与胞浆均有表达,且表达水平与mRNA水平一致;细胞周期结果显示,survivin表达较高的细胞株G2/M期细胞比例和增殖指数较高。结论:survivin基因在血液肿瘤细胞株中普遍表达,survivin高表达可能与肿瘤细胞增殖及耐药有关。 Objective: To explore the expression of survivin in different haematological tumor cell lines (Jurkat, Raji, FL-4, K562, K562/AO2). Methods: The levels of survivin mRNA and survivin protein were detected by RT-PCR and immunohistochemical staining, respectively, and the cell cycle profile was measured by flow cytometry. Results: Survivin mRNA expressed in four human cell lines (Jurkat, Raji, K562, K562/AO2) with varying levels and the roost highly in the K562/AO2. Survivin protein was detected in both nucleolus and cytoplasm in the four human cell lines, whose level is consistent with that of survivin mRNA. The higher the survivin mRNA expression was, the higher the proportion of G2/M phase cell and the proliferation index were. Conclusion: Survivin gene expresses in haematological tumor cell lines at large, its high expression may relate with tumor cell proliferation and drug resistance.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第6期593-596,共4页 Journal of Shandong University:Health Sciences
关键词 基因 SURVIVIN 血液肿瘤 RT-PCR 免疫组化 流式细胞仪 细胞株 Gene, survivin Hemotologic neoplasms RT-PCR Immunohistochemistry Flow cytometry Cell line
  • 相关文献

参考文献13

  • 1Ambaosini G,Adida C,Altier DC.A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J].Nature Med,1997,3(8):917-921.
  • 2Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax,caspases,and anticancer drugs[J].Cancer Res,1998,58(23):5 315-5 320.
  • 3Suzuki A,Ito T,Kawano H,et al.Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death[J].Oncogene,2000,19(10):1 346-1 353.
  • 4Nomura T,Yamasaki M,Nomura Y,et al.Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells[J].Oncol Rep,2005,14 (4):993-
  • 5Beardmore VA,Ahonen LJ,Gorbsky GJ,et al.Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity[J].J Cell Sci,2004,117(Pt 18):4 033-4 042.
  • 6Kallio MJ,Nieminen M,Eriksson JE,et al.Human inhibitor of apoptosis protein survivin participates in regulation of chromosome segregation and mitotic exit[J].FASEB J,2001,15(14):2 721-2 723.
  • 7Zaffaroni N,Daidone MG.Survivin expression and resistance to anticancer treatments:perspectives for new therapeutic interventions[J].Drug Resist Updat,2002,5 (2):65-72.
  • 8Wang L,Zhang GM,Feng ZH.Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line[J].Acta Pharmacol Sin,2003,24(12):1 235-1 240.
  • 9Yonesaka K,Tamura K,Kurata T,et al.Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin[J].Int J Cancer,2006,118(4):812-820.
  • 10Notarbartolo M,Cervello M,Poma P,et al.Expression of the IAPs in multidrug resistant tumor cells[J].Oncol Rep,2004,11(1):133-136.

同被引文献15

  • 1李娟,赵莹,张殿宝,黄蓓晖.Survivin在多发性骨髓瘤患者骨髓细胞中的表达及其临床意义[J].癌症,2005,24(12):1522-1526. 被引量:13
  • 2包悍英,蔡真.survivin mRNA表达水平与高三尖杉酯碱诱导恶性血液病细胞凋亡的相关性研究[J].浙江大学学报(医学版),2006,35(2):204-208. 被引量:3
  • 3Fortugno P, Wall N R, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function [J]. J Cell Sci, 2002,115 (Pt 3) :575-585.
  • 4Yoo N J, Kim H S, Kim S Y, et al. Immunohistochemical Analysis of Smac/DIABLO Expression in Human Carcinomas and Sarcomas [J]. APMIS,2003,111(3):382-388.
  • 5Dharminder C, Paola N, Mugdha V, et al. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma [J]. Blood, 2007, 109(3) : 1220-1227.
  • 6Abe S, Hasegawa M,Yamamoto K, et al. Rapid induction of IAP family proteins and Smac/DIABLO expression after proapoptotic stimulation with doxorubicin in RPMI 8226 multiple myeloma cells [J]. Exp Mol Pathol, 2007, 83(3):405-412.
  • 7Lamson DW, Plaza SM. The anticancer effects of vitamin K[J]. Altern Med Rev, 2003,8(3) :303 -315.
  • 8Hitomi M, Yokoyama F, Kita Y, et al. Antitumor effects of vitamins K1 , K2 and K3 on hepatocellular carcinoma in vitro and in vivo [ J ]. Int J Oncol, 2005,26 ( 3 ) : 713 - 720.
  • 9Nakagawa T, Matozaki S. The SKM-1 leukemic cell line established from a patient with progression to myelomono- cytic leukemia in myelodysplastic syndrome (MDS)-contri- bution to better understanding of MDS[ J]. Leuk Lympho- ma, 1995,17(3 -4) :335 -339.
  • 10Suzuki A, Ito T, Kawano H, et al. Survivin initiates pro- caspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death [ J ]. Onco- gene, 2000,19 (10) : 1346 - 1353.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部